AWCBR in Christchurch
Join the Largest Neuroscience Meeting in New Zealand – AWCBR 2025!
The Australasian Winter Conference for Brain Research is returning in 2025, bringing together world-leading neuroscientists, clinicians, and innovators to inspire cutting-edge research and collaboration.
To improve accessibility and foster an even stronger community, AWCBR 2025 is moving to the Garden City – Christchurch, New Zealand! Experience an exciting program featuring groundbreaking research, dynamic networking events, exclusive workshops, and expert-led panels. Present your work through poster and oral sessions, and engage with a global audience.
Travel and childcare support grants are available for students and postdocs, ensuring inclusivity for all. Set against the breathtaking backdrop of Christchurch, this is where innovation meets inspiration.
Don’t miss out—be part of AWCBR 2025!
Key Dates
23/03/2025 | Abstract Submissions open |
02/06/2024 | Early Bird Registration Open |
23/06/2025 | Abstract submission deadline |
18/07/2025 | Early bird registration ends |
18/08/2025 | Registration closes |
31/08/2025 | Conference opens |
04/09/2025 | Conference Closes |
Stunning New Venue
We’re thrilled to announce that the Australasian Winter Conference for Brain Research (AWCBR) 2025 will be held at Te Pae Christchurch Convention Centre! Located in the heart of the Garden City, Te Pae is a world-class venue designed for collaboration and innovation.
With stunning modern architecture, state-of-the-art facilities, and breathtaking views of the Ōtākaro Avon River, Te Pae offers the perfect setting for cutting-edge neuroscience discussions. Enjoy seamless conference experiences with high-tech presentation spaces, premium networking areas, and easy access to Christchurch’s vibrant restaurants, cafes, and green spaces.
A Unique Plenary Experience
Tak W. Mak, OC, PhD, DSc (Hons), FRSC, FRS
Senior Staff Scientist, OCI, Princess Margaret Cancer Centre at University Health Network
Professor, Department of Medical Biophysics & Immunology
University of Toronto
Co-Director, Centre for Oncology and Immunology
Hong Kong Science Park
Honorary Professor, Department of Pathology
School of Clinical Medicine, Li Ka Shing Faculty of Medicine
University of Hong Kong
Tak W. Mak is internationally known for his pioneering work on the genetics and molecular biology of cancer and the immune system. In 1984, his group cloned the gene encoding the human TCRβ chain, providing the basis for CAR-T treatment. His team also showed that CTLA4 negatively regulates T cell activation, paving the way for checkpoint inhibitor immunotherapy. Most recently, his team established that the brain communicates with the immune system via T and B cells producing acetylcholine.
In the biotech arena, Dr. Mak co-founded Agios Pharmaceuticals and Treadwell Therapeutics. These companies specialize in delineating metabolic vulnerabilities in tumour cells that can be exploited as novel cancer therapies. Two IDH inhibitors are now FDA-approved for AML treatment, and two first-in-class agents targeting aneuploidy in advanced tumours are now in phase II clinical trials.
Dr. Mak has published over 1000 peer-reviewed research papers, holds dozens of patents, and
has won numerous awards.
We’re excited to announce that this year’s Plenary Lecture will take place in the UNESCO award-winning heritage building – The Great Hall, Te Matatiki Toi Ora.
This breathtaking venue, rich in history and architectural beauty, will provide a truly inspiring setting for one of the conference’s most anticipated events.
With its stunning stained-glass windows, soaring timber ceilings, and grand ambiance, The Great Hall blends heritage charm with modern prestige. As a space that has long celebrated knowledge and creativity, it is the perfect backdrop for an unforgettable plenary session.
Thank you to our Sponsors
Diamond Sponsor
Gold Sponsor
Silver Sponsor
